Ring chromosome 14 syndrome (r(14) syndrome) is a rare genetic disease with an unknown prevalence. It affects both males and females. Signs of the condition often appear in infancy. R(14) syndrome arises because of alterations to chromosome 14 during the early stages of development, resulting in the formation of an unstable ring chromosome. It is unclear whether this occurs before or after conception [1]. There are numerous ring chromosome syndromes recorded in the literature. A mosaic form of r(14) syndrome has been reported, which exhibits fewer clinical symptoms than the non-mosaic form [2].

One of the main features of r(14) syndrome is early onset epilepsy that is drug resistant and, in some cases, severe [3]. Epilepsy is a feature that has been reported in all affected individuals, and seizures may occur in any form, including generalized, partial, tonic-clonic, myoclonic, or focal [4]. Some patients proceed to status epilepticus. There is now evidence suggesting that the seizures experienced are focal seizures that may or may not progress to generalized convulsions [5]. Often, seizures are hypnagogic, hypnopompic, or occur during sleep. The frequency of the seizures changes as the disease progresses, and some patients may respond partially to drugs.

The R(14) syndrome is also typified by intellectual impairment and developmental delay, including speech delay [6]. Epilepsy that is more severe, or begins at an earlier age, is associated with a higher degree of intellectual impairment in affected individuals [7].

Typical physical manifestations of the disease include hypotonia, microcephaly, flat occiput, flat nasal bridge, anteverted nostrils, high arched palate, prominent epicanthal folds, and low set ears. Short neck or short stature may also be present. The skin and eyes (particularly the retina) may be affected by various pigmentation disorders, which may be observed as discoloration of skin, and retinopathy. There are numerous possible ocular abnormalities, such as strabismus, myopia and, less commonly, microphthalmia and colobomas [6] [8].

Other possible signs and symptoms of the condition include scoliosis, bone diseases and gastrointestinal complaints. Children with r(14) syndrome are at a higher risk of acquiring infections, particularly respiratory infections [9]; these vary in severity, and may require hospitalization.

Definitive diagnosis of ring chromosome 14 syndrome can only be made via genetic testing, such as karyotyping [10]. Although the identification of r(14) syndrome may be challenging, as none of its characteristic features are exclusive to the syndrome, clinicians may begin to suspect and test for it in cases of refractory epilepsy with the occurrence of neurological or psychological symptoms [11]. The recommended cytogenetic test is an array CGH (comparative genomic hybridization) analysis.

Routine labs such as a complete blood count, liver function test, urea and electrolytes, thyroid function tests, are recommended. Radiological examination may involve magnetic resonance imaging (MRI). Neurological, ophthalmologic and psychological examination are also important initial investigations. EEG (electroencephalography) is required, and may reveal slow wave activity with intermittent spiking [4] [5].

There is no cure for Ring Chromosome 14 Syndrome, so treatment focuses on managing symptoms and improving quality of life. Seizures are often treated with antiepileptic medications. Early intervention programs, including physical, occupational, and speech therapy, can help address developmental delays. Regular monitoring by a team of specialists, including neurologists, geneticists, and developmental pediatricians, is crucial for comprehensive care.

The prognosis for individuals with Ring Chromosome 14 Syndrome varies widely depending on the severity of symptoms and the presence of associated health issues. While some individuals may achieve a degree of independence, others may require lifelong support. Early diagnosis and intervention can improve outcomes by addressing developmental and medical needs promptly.

Ring Chromosome 14 Syndrome is caused by a chromosomal abnormality where chromosome 14 forms a ring. This occurs due to the loss of genetic material at the ends of the chromosome, which then joins to form a circular structure. The exact cause of this chromosomal change is not well understood, but it is typically a random event that occurs during the formation of reproductive cells or in early fetal development.

Ring Chromosome 14 Syndrome is extremely rare, with only a few dozen cases reported in the medical literature. Because of its rarity, the exact prevalence is unknown. It affects both males and females equally and has been identified in various ethnic groups worldwide.

The pathophysiology of Ring Chromosome 14 Syndrome is related to the loss of genetic material from chromosome 14, which disrupts normal development and function. The specific genes affected by this loss can vary, leading to the diverse range of symptoms observed in affected individuals. The formation of the ring chromosome can also lead to instability during cell division, potentially causing further genetic imbalances.

Currently, there are no known methods to prevent Ring Chromosome 14 Syndrome, as it is a genetic condition that occurs spontaneously. Genetic counseling may be beneficial for families with a history of chromosomal abnormalities to understand potential risks in future pregnancies.

Ring Chromosome 14 Syndrome is a rare genetic disorder resulting from a chromosomal abnormality. It is characterized by developmental delays, intellectual disabilities, and seizures, among other symptoms. Diagnosis involves genetic testing, and treatment focuses on managing symptoms and supporting development. While the condition is not preventable, early intervention can improve quality of life for affected individuals.

For patients and families affected by Ring Chromosome 14 Syndrome, understanding the condition is crucial. It is a rare genetic disorder caused by a change in chromosome 14, leading to a variety of symptoms, including developmental delays and seizures. While there is no cure, treatments are available to manage symptoms and support development. Working closely with a team of healthcare professionals can help address the unique needs of each individual.

1. Rossi E, Riegel M, Messa J, et al. Duplications in addition to terminal deletions are present in a proportion of ring chromosomes: clues to the mechanisms of formation. J Med Genet. 2008;45(3):147-154.
2. Matalon R, Supple P, Wyandt H, Rosenthal IM. Transmission of ring 14 chromosome from mother to two sons. Am J Med Genet. 1990;36(4):381-385.
3. Incecik F, Hergüner MO, Mert G, Erdem S, Altunbaşak S. Ring chromosome 14 syndrome presenting with intractable epilepsy: a case report. Turk J Pediatr. 2013;55(5):549-551.
4. Imataka G, Noguchi M, Tsukada K, Takahashi T, Yamanouchi H, Arisaka O. Partial epilepsy and developmental delay in infant with ring chromosome 14. Genet Couns. 2013;24(1):81-83.
5. Giovannini S, Marangio L, Fusco C, et al. Epilepsy in ring 14 syndrome: a clinical and EEG study of 22 patients. Epilepsia. 2013;54(12):2204-2213.
6. Zollino M, Seminara L, Orteschi D, et al. The ring 14 syndrome: clinical and molecular definition. Am J Med Genet A. 2009;149A(6):1116-1124.
7. Zampini L, D’Odorico L, Zanchi P, Zollino M, Neri G. Linguistic and psychomotor development in children with chromosome 14 deletions. Clin Linguist Phon. 2012;26(11-12):962-973.
8. Salter CG, Baralle D, Collinson MN, Self JE. Expanding the ocular phenotype of 14q terminal deletions: A novel presentation of microphthalmia and coloboma in ring 14 syndrome with associated 14q32.31 deletion and review of the literature. Am J Med Genet A. 2016;170A(4):1017-1022.
9. Specchio N, Trivisano M, Serino D, et al. Epilepsy in ring 14 chromosome syndrome. Epilepsy Behav. 2012;25(4):585-592.
10. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749-764.
11. Redin C, Gérard B, Lauer J, et al. Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing. J Med Genet. 2014;51(11):724-736.